Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
February 12, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 4
Source: SEC/Edgar
February 05, 2012
Form 3
Source: SEC/Edgar
December 11, 2011
Form 3
Source: SEC/Edgar
December 11, 2011
Form 4
Source: SEC/Edgar
November 22, 2011
Form 4
Source: SEC/Edgar
November 15, 2011
Form 4
Source: SEC/Edgar
November 14, 2011
Form 4
Source: SEC/Edgar
August 10, 2011
Form 4
Source: SEC/Edgar
August 09, 2011
Form 4
Source: SEC/Edgar
August 09, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 10, 2011
Form 4
Source: SEC/Edgar
May 08, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
May 05, 2011
Form 4
Source: SEC/Edgar
February 03, 2011
Form 4
Source: SEC/Edgar
February 03, 2011
Form 4
Source: SEC/Edgar
February 03, 2011
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.